<DOC>
	<DOC>NCT01044264</DOC>
	<brief_summary>A randomized, double-blind, multiple-site, placebo-controlled, parallel-group clinical study conducted to evaluate the bioequivalence of two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel formulations.</brief_summary>
	<brief_title>Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>healthy men or women, 12 years of age and older willing to participate and sign a copy of the informed consent form moderate to severe facial acne history of allergy or hypersensitivity to clindamycin or benzoyl peroxide pregnant or lactating women evidence of a clinically significant disorder receipt of any drugs as part of a research study within 30 days prior to study dosing use of systemic, topical or facial products which may interfere with study significant facial hair, tattoos, excessive facial scarring, active facial sunburn, or peeling due to sunburn</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>bioequivalency</keyword>
	<keyword>clindamycin</keyword>
	<keyword>benzoyl peroxide</keyword>
</DOC>